Edition:
United Kingdom

People: Prothena Corporation PLC (PRTA.OQ)

PRTA.OQ on NASDAQ Stock Exchange Global Select Market

9.71USD
9:00pm BST
Change (% chg)

$-0.16 (-1.62%)
Prev Close
$9.87
Open
$9.96
Day's High
$10.10
Day's Low
$9.67
Volume
45,354
Avg. Vol
111,539
52-wk High
$15.91
52-wk Low
$8.66

Cooke, Shane 

Mr. Shane M. Cooke is Independent Director of Prothena Corporation plc., since December 2012. He is the former President of Alkermes plc (a biopharmaceutical company), a position he held from 2011 to 2018. Prior to that, he served as Head of Elan Drug Technologies and Executive Vice President of Elan Corporation, plc (from 2007 to 2011), where he also served as Chief Financial Officer (from 2001 to 2011) and as a director (from 2005 to 2011). Mr. Cooke has also held a number of senior positions in finance in the banking and aviation industries. He is also a director of Alkermes plc and Endo International plc. Mr. Cooke earned his Bachelor of Commerce and Master of Accounting degrees from University College Dublin, Ireland, and is a chartered accountant. He has served on our Board since 2012.

Basic Compensation

Total Annual Compensation, USD 74,370
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 435,067
Fiscal Year Total, USD 509,437

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Lars Ekman

526,938

Gene Kinney

5,148,240

Tran Nguyen

3,260,720

Karin Walker

--

Wagner Zago

--

Arthur Homan

2,479,620
As Of  31 Dec 2017